Journal article
Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention
Abstract
Bivalirudin is an alternative to unfractionated heparin (UFH) anticoagulation during percutaneous coronary intervention. Previously, we have reported clinical benefit on major bleeding in favor of bivalirudin compared with UFH monotherapy but inconclusive results on mortality. Controversial data have been reported in the last 2 years. We conducted an updated meta-analysis including randomized trials and observational studies, which evaluated …
Authors
Perez AEB; Rao SV; Jolly SJ; Pancholy SB; Plourde G; Rimac G; Poirier Y; Costerousse O; Bertrand OF
Journal
The American Journal of Cardiology, Vol. 117, No. 8, pp. 1256–1266
Publisher
Elsevier
Publication Date
4 2016
DOI
10.1016/j.amjcard.2016.01.015
ISSN
0002-9149